際際滷

際際滷Share a Scribd company logo
Targos
Biomarker Meeting 2013
February 25  26
Waldgut
Schloss H旦hnscheid
Bad Arolsen  H旦hnscheid
Germany
Targos
Welcometothe
TargosBiomarkerMeeting2013
February25-26,2013
WaldgutSchlossH旦hnscheid,
34454BadArolsenH旦hnscheid,Germany
Agenda
Sunday,February24
11.00am11.00pmArrivalofparticipants
6.00-9.00pmInformaldinner
Monday,February25
Moderator:
UniversityofSouthernCalifornia,LosAngeles.USA
Venue:
7.30amBreakfast
9.00amPick-up,TraveltoTargosbybus
Onbus:
IntroductionofTargosand
PathologieNordhessen
10.00amArrival-Targos
10.1510.45amTargosfacilitytour
10.4511.15amPathologieNordhessenfacilitytour
11.1511.30amBREAK
11.3012.00noonIntroductionofspeakersandindustry
participants
Targos
12.0012.45pmLUNCH
1.001.30pmFDAperspectiveonpredictive
biomarkers
UniversityofSouthernCalifornia
LosAngeles,USA
1.302.00pmPredictivebiomarkersinlymphomas
2.002.30pmPredictivebiomarkersinmelanoma
Center,Houston,USA
2.303.00pmPredictivebiomarkersinbreastcancer
3.003.30pmBREAK
3.304.00pmPredictivebiomarkersandgenomic
strategiesforrationalcombinationof
targetedtherapies
4.004.30pmPredictivebiomarkertestinginBrazil
4.30pmBustoWaldgutSchlossH旦hnscheid
6.007.00pmDINNER
7.008.30pmDiscussionandperspectivefrom
industryparticipants
8.30pmClose-outofthedayatthefireplace
Tuesday,February26
Moderator:
Venue:WaldgutSchlossH旦hnscheid
7.158.15amBreakfast
8.309.00amRoleofcentralpathologyreviewinclinical
trailsforbreastcancerpatients
9.009.30amPredictivebiomarkersin
colorectalcancer
9.3010.00amPredictivebiomarkersinstomachcancer
10.0011.00amBREAK/GroupPhoto
11.0011.30amPredictivebiomarkersinNSCLC
11.3012.00pmPredictivebiomarkersinSCLC/NSCLC
Germany
12.0012.30pmPredictivebiomarkersinsarcomas
CenterG旦ttingen
12.301.30pmLUNCH
1.303.00pmGeneraldiscussionandwrap-upofmeeting
3.00pmCloseofthebiomarkermeeting
CliveRoyTaylor,MD,DPhil,MRCP(Ir),FRCPath
UniversityofSouthernCalifornia,LosAngeles.USA
-
-
-
--------------------------------------------------------
PhilippeGaulard,MD
malignancies.Hemaintainsanimportantpracticeofhematopathology
comprisingmanyconsultationcases,istheformermedicaldirectorof
-
gistsfromFranceandseveralneighbouringEuropeancountriesconduc-
lymphomaentitiesincludingprimarymediastinallargeB-celllymphoma
toimprovethediagnosisoflymphomas,andcontributetobettermanage-
-
nationalandinternationalcongresses.
--------------------------------------------------------
AlexanderLazar,MD,PhD
pathogenesis,andtargetedtherapiesforsarcoma&melanomainthe
Center.Heisinvolvedinmultiplecollaborative,laboratory-basedre-
-
-
-
-
larmodeling,heisfocusedonintegratingmolecularmarkersintocancer
forreportingclinicalmoleculardiagnostictestinginsolidtumors.Onthe
authoredmorethan200publicationsonnumerousaspectsofskinand
-
--------------------------------------------------------
SunilBadve,MD
SunilBadvereceivedhismedicaldegreeandpathologyresidencyatGrant
-
-
bookchapters.HeservesastheassociateeditorofClinicalBreastCancer
speakeratnationalandinternationalpathologymeetingsandhascon-
-
--------------------------------------------------------
BrianLeyland-Jones,MBBS,PhD
recentlyservedasassociatevicepresidentanddirectoroftheEmory
atMcGillUniversityinMontreal,Canada.
-
-
--------------------------------------------------------
VenancioAvanciniFerreiraAlves,MD,PhD
ofeventsfromviralhepatitisandsteato-hepatitistocirrhosistoliver
biomarkersusefulfordiagnosisand,morerecently,fortargetedtumor
--------------------------------------------------------
GiuseppeViale,MD,FRCPath
CollaborativeGroupSteeringCommittee,andheisFoundingMemberof
Hehasbeenactiveinclinicalandtranslationalresearchesonbreast
36chaptersinbooks
--------------------------------------------------------
BharatJasani,MBChB,PhD,FRCPath
-
-
tegicplanstomodernisehistopathologyservice,andthedevelopment
ofdiagnosticimmunocytochemistry&molecularpathologyservicein
andstandardisationofcancerbiomarkeranalysesastheBreastCancer
-
fortranslationalresearchprojectstargetedatdevelopingpredictivebio-
intra-operativemethodforsentinellymphnodebreastcancermetastases.
-
Medicine.
--------------------------------------------------------
JosefR端schoff,MD
-
-
CancerSociety.
Hehasparticipatedinmorethan100clinicaltrailspertainingtobreast,
-
-
-
ledtrial.
-
Heisarecipientofmanygrantsandaconsultanttosomepublic
corporations.
--------------------------------------------------------
ManuelSalto-Tellez,MD,FRCPath
andgenotypeinbothdiagnosticsandtranslationalresearch.
inmanynationalandinternationalconferences.Hisareasofdiagnosticin-
terestaregastrointestinalpathologyandmoleculardiagnosis.Hisareasof
researchinterestincludethediscoveryandvalidationofnovelmolecular
biomarkersofdisease,thevalidationandtechnologytransferofnoveldis-
coveriesintothemoleculardiagnosticpracticeandthemolecularpatho-
--------------------------------------------------------
ReinhardB端ttner,MD
inhigh-impactjournals.Somerepresentativepublicationssince2010are;
integrativegenomeanalysesandScienceTranslMed,inpress2012;
andpubliccorporations.
--------------------------------------------------------
PhilippStr旦bel,MD
-
ofimatinibandsunitinibinthymiccarcinomasandco-authorshipsinmany
-
thologyattheUniversityMedicalCenterMannheim,UniversityofHeidel-
CenterG旦ttingen.Hismainresearchinterestsaremolecularpathology
JohnLowe,MD
--------------------------------------------------------
HartmutKoeppen,MD,PhD
--------------------------------------------------------
Dr.H.-J.Grote
HeadofHistopathologyinBiomarkerTechnologiesatMerckKGaA,Germany
--------------------------------------------------------
WernerKroll.GlobalHeadofResearch.MDx.
--------------------------------------------------------
PilarGarin-Chesa,MD,PhD
--------------------------------------------------------
HaraldBerninger
--------------------------------------------------------
Dr.B辰rbelPorstmann
--------------------------------------------------------
HenrikWinther,DVM,PhD
--------------------------------------------------------
AboutTargos
-
mentandapplicationofclinicalbiomarkersfortheinternationalpharma-
ceuticalanddiagnosticindustry.
Thecompanyhassupportedmorethan100internationalclinicaltrials
pathologistsisembeddedinaprofessionalenvironmentofprojectma-
-
toryimprovementprograms.
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
2011 European Frost &
Service Leadership
Targos
Germaniastrasse 7
thomas.henkel@targos-gmbh.de
Tel: +49-561-50045300

More Related Content

Targos Biomarker Meeting 2013_lores